2004
DOI: 10.1016/j.it.2004.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(21 citation statements)
references
References 48 publications
0
21
0
Order By: Relevance
“…IL-15 is currently proposed as adjuvant immunotherapy for HIV ϩ individuals (18,53,54) and has also been shown to curtail infections by human herpesviruses (33). Our data indicate that it may also be beneficial in HCV infection, where IFN-␣ treatment is already used, and may potentially be useful in other chronic infections too.…”
Section: Cd28mentioning
confidence: 69%
“…IL-15 is currently proposed as adjuvant immunotherapy for HIV ϩ individuals (18,53,54) and has also been shown to curtail infections by human herpesviruses (33). Our data indicate that it may also be beneficial in HCV infection, where IFN-␣ treatment is already used, and may potentially be useful in other chronic infections too.…”
Section: Cd28mentioning
confidence: 69%
“…Because of IL-15's exquisite specificity -in terms of both its selective targeting of T EM and transitional memory T cell populations and its focus on proliferation rather than other aspects of activation -we would posit that IL-15 therapy would enhance CD4 + T EM cell reconstitution without the deleterious effects of generalized immune activation. Moreover, the ability of IL-15 to promote CD8 + T EM cell expansion, survival, and function (18,24,25,45) would likely enhance immunity against HIV and opportunistic pathogens, providing further benefit. Indeed, we demonstrate IL-15-mediated induction of proliferation for both SIV-and CMV-specific CD8 + T cells here ( Figure 9C).…”
Section: Figurementioning
confidence: 99%
“…Thus, IL-15 promotes extrathymic development of T and NK cells (22), is a growth, differentiation, activation, and survival factor for NK cells that contributes to increased cytolytic activity of NK cells, stimulation of cytokine (IFN-␥) synthesis, and prolongation of NK cell survival (23,24). IL-15 is also a potent T cell growth factor that enhances the survival, activation, IFN-␥ production, and cytotoxicity of CD8 ϩ T cells and has an important role in regulating CD8 ϩ T cell homeostasis (25). IL-15 regulates both proliferation and Ab production by activated B cells (26), while mast cells proliferate in response to IL-15 and produce functionally active IL-4 (27).…”
Section: Molecular and Functional Characterization Of Il-15 In Rainbomentioning
confidence: 99%